New developments in the treatment of metastatic gastric cancer: focus on trastuzumab

por Rose, Jeffrey S, Bekaii-Saab, Tanios S
Publicado 2011

CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer

por Wu, Christina, Bekaii-Saab, Tanios
Publicado 2012

Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”

por Zhu, Mojun, Bekaii-Saab, Tanios
Publicado 2022

Management of Venous Thromboembolism in Patients with Advanced Gastrointestinal Cancers: What Is the Role of Novel Oral Anticoagulants?

por Martin, Ludmila Katherine, Bekaii-Saab, Tanios
Publicado 2012

Identifying and targeting cancer stem cells in the treatment of gastric cancer

por Bekaii‐Saab, Tanios, El‐Rayes, Bassel
Publicado 2017

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies

por Ahn, Daniel H., Bekaii-Saab, Tanios
Publicado 2017

Response to Drs Von Hoff and Renschler

por Ahn, Daniel H., Bekaii-Saab, Tanios
Publicado 2017

Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements

por Walden, Daniel, Eslinger, Cody, Bekaii-Saab, Tanios
Publicado 2022

Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives

por Bupathi, Manojkumar, Ahn, Daniel H, Bekaii-Saab, Tanios
Publicado 2016

Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma

por Ahn, Daniel H., Ramanathan, Ramesh K., Bekaii-Saab, Tanios
Publicado 2018

Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies

por Sonbol, Mohamad B., Ahn, Daniel H., Bekaii-Saab, Tanios
Publicado 2019

Frontline therapy for advanced hepatocellular carcinoma: an update

por Akce, Mehmet, El-Rayes, Bassel F., Bekaii-Saab, Tanios S.
Publicado 2022

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

por So, Brian J, Bekaii-Saab, Tanios, Bloomston, Mark A, Patel, Tushar
Publicado 2008

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

por Bekaii-Saab, Tanios, Williams, Nita, Plass, Christoph, Calero, Miguel Villalona, Eng, Charis
Publicado 2006

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vacci...

por Kaumaya, Pravin T. P., Guo, Linlin, Overholser, Jay, Penichet, Manuel L., Bekaii-Saab, Tanios
Publicado 2020

Adjuvant therapy for pancreas cancer in an era of value based cancer care

por Ahn, Daniel H., Williams, Terence M., Goldstein, Daniel A., El-Rayes, Bassel, Bekaii-Saab, Tanios
Publicado 2015

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors

por Ahn, Daniel H., Ozer, Hatice Gulcin, Hancioglu, Baris, Lesinski, Gregory B., Timmers, Cynthia, Bekaii-Saab, Tanios
Publicado 2015

Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma

por Prado, C M M, Bekaii-Saab, T, Doyle, L A, Shrestha, S, Ghosh, S, Baracos, V E, Sawyer, M B
Publicado 2012

Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical Outcomes

por Bekaii-Saab, Tanios S, Lach, Krzysztof, Hsu, Ling-I, Siadak, Muriel, Stecher, Mike, Ward, James, Beckerman, Rachel, Strickler, John H
Publicado 2023

Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer

por Pershad, Yash, Govindan, Siddharth, Hara, Amy K., Borad, Mitesh J., Bekaii-Saab, Tanios, Wallace, Alex, Albadawi, Hassan, Oklu, Rahmi
Publicado 2017